GeneDx Holdings
Update in progressWGS (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
GeneDx Holdings Corp is a genomics company that provides genetic testing services, with a primary emphasis on pediatric and rare disease diagnostics. It focuses on whole exome and whole genome sequencing, along with data and information services. The company also develops an AI-based platform for next-generation sequencing analysis, interpretation, and clinical reporting for rare diseases, hereditary risk, and cancer. Founded in 2000, based in Stamford, Connecticut.
Company score
- Sentiment
- -0.20
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.09
- Governance
- -0.24
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.02
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.11
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEOMs. Katherine A. Stueland
- Founded2000
- Employees1,300
- Websitewww.genedx.com
Identifiers
- ISINUS81663L2007
- FIGIBBG00XDHY5P9
- CUSIP81663L200
- CIK0001818331